2.5. Outcome measures
TNF-α
SECONDARY, SYNDROME, YANG DEFICIENCY
Change in the PASI and DLQI scores at baseline, 1 month, 40 days after treatment, and at 3 and 6 months of follow-up, as well as the Yang deficiency syndrome score at baseline and 40 days after treatment, were compared between the study arms to determine the treatment effectiveness. Laboratory results served as secondary outcomes. Interferon-gamma (IFN-γ), TNF-α, IL-4, IL-10, and IL-17 levels were measured in peripheral blood samples at baseline and after 40 days of treatment.